Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study

American Heart Journal

Volumn 160, Issue 3, 2010, Pages

  Shah, Svati H ^a   Granger, Christopher B ^a   Hauser, Elizabeth R ^a   Kraus, William E ^a   Sun, Jie Lena ^a   Pieper, Karen ^a   Nelson, Charlotte L ^a   Delong, Elizabeth R ^a   Califf, Robert M ^a,b   Newby, L Kristin ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; MOLECULAR MARKER; RNA;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL CLASSIFICATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENOMICS; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLOMICS; MICROARRAY ANALYSIS; MODEL; MOLECULAR BIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR MODEL; MUSCLE NECROSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; RISK ASSESSMENT; RNA ANALYSIS; TRANSCRIPTOMICS; TREATMENT RESPONSE; CARDIOVASCULAR DISEASES; CLASSIFICATION; GENETICS; METHODOLOGY; MYOCARDIAL INFARCTION; PATIENT SELECTION; PERSONALIZED MEDICINE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; UNITED STATES;

CARDIOVASCULAR DISEASES; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; NORTH CAROLINA; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 77956358731     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.051     Document Type: Article

References (26)

1. Wilson P.W., D'Agostino R.B., and Levy D. Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
2. Ridker P.M., Rifai N., and Rose L. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
3. Eagle K.A., Lim M.J., and Dabbous O.H. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733
4. Potti A., Mukherjee S., and Petersen R. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer N Engl J Med 355 2006 570 580
5. Helgadottir A., Thorleifsson G., and Manolescu A. A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 1491 1493
6. Sinnaeve P.R., Donahue M.P., and Grass P. Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease PLoS ONE e7037 2009 4
7. Wingrove J.A., Daniels S.E., and Sehnert A.J. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis Circulation: Cardiovascular Genetics 1 2008 31 38
8. Kraus W.E., Rosenberg S., and Elashoff M.R. Development and multi-center validation of a blood-based gene expression test for diagnosis of obstructive CAD in non-diabetic patients [abstract] Circulation 120 2009 S563
9. Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction Circulation 116 2007 2634 2653
10. Newby L.K., Christenson R.H., and Ohman E.M. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators Circulation 98 1998 1853 1859
11. Ohman E.M., Armstrong P.W., and Christenson R.H. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators N Engl J Med 335 1996 1333 1341
12. Morrow D.A., Cannon C.P., and Rifai N. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA 286 2001 2405 2412
13. Newby L.K., Ohman E.M., and Christenson R.H. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy Circulation 103 2001 2891 2896
14. Newby L.K., Storrow A.B., and Gibler W.B. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study Circulation 103 2001 1832 1837
15. Sabatine M.S., Morrow D.A., and de Lemos J.A. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 105 2002 1760 1763
16. Donahue M.P., Rose K., and Hochstrasser D. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma Am Heart J 152 2006 478 485
17. Brindle J.T., Antti H., and Holmes E. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics Nat Med 8 2002 1439 1444
18. Shah S.H., Hauser E.R., and Bain J.R. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease Mol Syst Biol 5 2009 258
19. Shah S.H., Bain J.R., and Muehlbauer M.J. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events Circulation Cardiovasc Gen 3 2010 207 214
20. Califf R.M., Harrell Jr.F.E., and Lee K.L. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective JAMA 261 1989 2077 2086
21. Jones R.H., Kesler K., and Phillips H.R. III Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease J Thorac Cardiovasc Surg 111 1996 1013 1025
22. Mark D.B., Nelson C.L., and Califf R.M. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty Circulation 89 1994 2015 2025
23. Smith P.K., Califf R.M., and Tuttle R.H. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit Ann Thorac Surg 82 2006 1420 1428
24. Johnson W.E., Li C., and Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods Biostatistics 8 2007 118 127
25. Ferrara C.T., Wang P., and Neto E.C. Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling PLoS Genet e1000034 2008 4
26. Pencina M.J., D'Agostino R.B. Sr., and D'Agostino Jr.R.B. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172